Compare IMCR & IMKTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMCR | IMKTA |
|---|---|---|
| Founded | 2008 | 1963 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Food Chains |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | 2016 | 1994 |
| Metric | IMCR | IMKTA |
|---|---|---|
| Price | $26.33 | $83.98 |
| Analyst Decision | Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $59.30 | N/A |
| AVG Volume (30 Days) | ★ 414.0K | 63.9K |
| Earning Date | 11-06-2026 | 11-30-2026 |
| Dividend Yield | N/A | ★ 0.78% |
| EPS Growth | ★ 30.39 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $249,428,000.00 | ★ $5,334,032,609.00 |
| Revenue This Year | $9.28 | N/A |
| Revenue Next Year | $9.91 | N/A |
| P/E Ratio | ★ N/A | $15.91 |
| Revenue Growth | ★ 43.05 | N/A |
| 52 Week Low | $26.53 | $67.92 |
| 52 Week High | $40.71 | $95.62 |
| Indicator | IMCR | IMKTA |
|---|---|---|
| Relative Strength Index (RSI) | 32.57 | 46.77 |
| Support Level | N/A | $82.10 |
| Resistance Level | $31.75 | $84.55 |
| Average True Range (ATR) | 1.46 | 2.03 |
| MACD | -0.46 | 0.01 |
| Stochastic Oscillator | 9.12 | 35.55 |
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
Ingles Markets Inc is a U.S.-based company that is principally engaged in operating a supermarket chain. The company operates the business in the southeast United States, mainly in Georgia, North Carolina, South Carolina, and Tennessee, with a few stores in Virginia and Alabama as well. The company locates its stores majorly in suburban areas, small towns, and neighborhood areas. It offers a broad range of goods, including food products, pharmacies, health and beauty care products, and general merchandise. The retail business contributes the majority of the company's revenue. The company's real estate ownership of a material portion of total stores enables it to generate rental income.